CAROLYN SIMS: Open Payments
NPI 1407957087 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$779 in 16 payments from 9 companies in 2025. Trend: 2023 $260 · 2024 $932 · 2025 $779
Food & beverage: $779
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $304 |
| Incyte Corporation | 1 | $132 |
| Arcutis Biotherapeutics, Inc. | 2 | $128 |
| UCB, Inc. | 2 | $51 |
| ABBVIE INC. | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 1 | $40 |
| LEO Pharma Inc. | 1 | $28 |
| PFIZER INC. | 1 | $25 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $23 |
Products named: DUPIXENT, Zoryve, Bimzelx, SKYRIZI, ADBRY, CIBINQO, RINVOQ.
Industry payments across GA — which companies pay providers there.
